452 related articles for article (PubMed ID: 34287797)
1. Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells.
Menyailo ME; Bokova UA; Ivanyuk EE; Khozyainova AA; Denisov EV
Mol Diagn Ther; 2021 Sep; 25(5):549-562. PubMed ID: 34287797
[TBL] [Abstract][Full Text] [Related]
2. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
6. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).
Tayoun T; Faugeroux V; Oulhen M; Aberlenc A; Pawlikowska P; Farace F
Cells; 2019 Sep; 8(10):. PubMed ID: 31557946
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
10. The biology and clinical potential of circulating tumor cells.
Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
Menyailo ME; Tretyakova MS; Denisov EV
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
Mentis AA; Grivas PD; Dardiotis E; Romas NA; Papavassiliou AG
Cell Mol Life Sci; 2020 Sep; 77(18):3671-3690. PubMed ID: 32333084
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
14. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
[TBL] [Abstract][Full Text] [Related]
15. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
De Souza LM; Robertson BM; Robertson GP
Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
17. Targeting circulating tumor cells to prevent metastases.
Gostomczyk K; Marsool MDM; Tayyab H; Pandey A; Borowczak J; Macome F; Chacon J; Dave T; Maniewski M; Szylberg Ł
Hum Cell; 2024 Jan; 37(1):101-120. PubMed ID: 37874534
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
20. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]